A Phase I Study to Assess the Safety, Tolerability, and Pharmacokinetics of CXD101 in Patients With Advanced Cancer
Cancer - United States
doi 10.1002/cncr.31791
Full Text
Open PDFAbstract
Available in full text
Date
October 17, 2018
Authors
Publisher
Wiley